Trial Profile
The Effect of BP-C1 in Treatment of Inoperable Pancreatic Cancer Patients: A Single Centre Pilot Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Nov 2018
Price :
$35
*
At a glance
- Drugs BP-C1 (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Meabco
- 28 Jun 2017 New trial record
- 06 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology